<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53721">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02005731</url>
  </required_header>
  <id_info>
    <org_study_id>LSWT-004-EU</org_study_id>
    <nct_id>NCT02005731</nct_id>
  </id_info>
  <brief_title>Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction</brief_title>
  <acronym>LISW</acronym>
  <official_title>A Prospective Pilot Study to Assess the Safety and Efficacy of Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' in Patients With Erectile Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Initia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Initia</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, pilot study for assessing the safety and efficacy of the treatments
      performed with Renova (LI-ESWT) on symptomatic ED patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change from baseline in the IIEF-EF (International Index of Erectile Function- Erectile Function Domain) score at 1, 3 and 6 months post treatment</measure>
    <time_frame>1, 3 and 6 months post treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the SEP (Sexual Encounter Profile) Questions 2 and 3 at 1, 3 and 6 months post treatment</measure>
    <time_frame>1, 3 and 6 months post treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Responses to the GAQ (Global Assessment questions) Questions 1 and 2 at 1, 3 and 6 months post treatment</measure>
    <time_frame>1, 3 and 6 months post treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">58</enrollment>
  <condition>Vasculogenic Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Shockwaves</arm_group_label>
    <description>Low intensity linear focused shockwave device ('Renova')</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low intensity linear focused shockwave device ('Renova')</intervention_name>
    <arm_group_label>Shockwaves</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Sexual Medicine clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good general health

          -  Vasculogenic ED for at least 6 months

          -  International Index of Erectile Function 6 (IIEF-EF) between 11 to 25

          -  Positive response to PDE5-I (able to penetrate on demand, Responders)

          -  Negative response to PDE5-I (unable to penetrate on demand even with maximum PDE5-I
             dosage,Non-responders)

          -  Stable heterosexual relationship for more than 3 months

        Exclusion Criteria:

          -  Psychogenic ED

          -  Neurological pathology

          -  Hormonal pathology

          -  Past radical prostatectomy

          -  Recovering from cancer during last 5 years

          -  Any unstable medical, psychiatric, spinal cord injury and penile anatomical   -
             abnormalities

          -  Clinically significant chronic hematological disease

          -  Anti-androgens, oral or injectable androgens

          -  Radiotherapy in pelvic region
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cobi Reisman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Men's Health Clinic, Amstelland Hospital, Amsterdam, The Netherlands</affiliation>
  </overall_official>
  <reference>
    <citation>Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010 Aug;58(2):243-8. doi: 10.1016/j.eururo.2010.04.004. Epub 2010 May 6.</citation>
    <PMID>20451317</PMID>
  </reference>
  <reference>
    <citation>Goyal NK, Garg M, Goel A. Re: Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study: Y. Vardi, B. Appel, A. Kilchevsky and I. Gruenwald. J Urol 2012; 187: 1769-1775. J Urol. 2012 Nov;188(5):2018-9. doi: 10.1016/j.juro.2012.07.052. Epub 2012 Sep 20.</citation>
    <PMID>22999553</PMID>
  </reference>
  <reference>
    <citation>Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002 Aug;14(4):226-44. Review.</citation>
    <PMID>12152111</PMID>
  </reference>
  <reference>
    <citation>Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011 Nov;60(5):1010-6. doi: 10.1016/j.eururo.2011.07.053. Epub 2011 Jul 30.</citation>
    <PMID>21855209</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 15, 2013</lastchanged_date>
  <firstreceived_date>December 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Low Intensity Shockwave</keyword>
  <keyword>Extracorporeal shockwave therapy</keyword>
  <keyword>Erectile dysfunction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
